Results 181 to 190 of about 190,081 (230)

Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging. [PDF]

BMJ Oncol
Shahraz S, Wong OY, Chotai R, Knight S, Globe D, Patel MJ, Kaushik A, Aiyegbusi OL, Calvert M.   +8 more
europepmc   +1 more source

Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations. [PDF]

Front Immunol
Nova D, Pagliari GG, Mambrito S, Cortinovis DL, Canova S.   +4 more
europepmc   +1 more source

Contemporary Spanish Grammar: grammar of the language grammar speech

Revista MENDIVE, 2013
Ada de la Caridad Mirabal Asco
doaj  

Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities. [PDF]

Clin Transl Sci
Mehanna M, Mody H, Hsu JC, Quintanilha J, Taylor ZL, James A, Rajbanshi B, Manchandani P, Chekka LM.   +8 more
europepmc   +1 more source

Integrated network pharmacology, molecular docking, and experimental validation reveal the antifungal and anti-inflammatory mechanisms of Camellia oleifera seed extracts against oral thrush. [PDF]

Sci Rep
Zhang X, Zeng X, Zheng M, Qiu X, Zhang F, Shi Q.   +5 more
europepmc   +1 more source

Referral delays in metastatic breast cancer care: barriers and facilitators across a fragmented pathway. [PDF]

BMJ Open Qual
Peerawong T, Phenwan T, Supanichwatana S, Siammai N, Sunthorn P, Gray NM.   +5 more
europepmc   +1 more source

Eligibility criteria and study phase limit racial/ethnic enrollment in oncology clinical trials. [PDF]

BMC Cancer
Arizpe A, Nieva J, Pickering TA, Liu L, Scampavia L, Ferrin J, Farias AJ.   +6 more
europepmc   +1 more source